Pure Bioscience (PURE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 07/31
(Values in U.S. thousands)
| 10-2025 | 07-2025 | 04-2025 | 01-2025 | 10-2024 | |
| Sales | 708 | 764 | 491 | 391 | 556 |
| Cost of Goods | 258 | 296 | 208 | 164 | 231 |
| Gross Profit | 450 | 468 | 283 | 227 | 325 |
| Operating Expenses | 1,087 | 1,100 | 1,075 | 1,116 | 1,183 |
| Operating Income | -379 | -336 | -584 | -725 | -627 |
| Interest Expense | 94 | 89 | 78 | 70 | 62 |
| Other Income | 9 | 93 | 82 | -3 | 0 |
| Pre-tax Income | -464 | -332 | -580 | -798 | -689 |
| Net Income Continuous | -464 | -332 | -580 | -798 | -689 |
| Net Income | $-464 | $-332 | $-580 | $-798 | $-689 |
| EPS Basic Total Ops | 0.00 | 0.01 | -0.01 | -0.01 | -0.01 |
| EPS Basic Continuous Ops | 0.00 | 0.00 | -0.01 | -0.01 | -0.01 |
| EPS Diluted Total Ops | 0.00 | 0.01 | -0.01 | -0.01 | -0.01 |
| EPS Diluted Continuous Ops | 0.00 | 0.00 | -0.01 | -0.01 | -0.01 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.01 | -0.01 | -0.01 | -0.01 |
| EBITDA(a) | $-378 | $-336 | $-583 | $-725 | $-627 |